[1] | Xie A, Wang S, Zhang K, et al. Treatment with interleukin-12/23p40 antibody attenuates acute cardiac allograft rejection. Transplantation, 2011, 91(1):27-34. (CI 15). |
[2] | Aini Xie, Eric Dale Buras, Jiahong Xia , et al. The Emerging Role of Interleukin-21 in Transplantation, J Clin Cell Immunol, 2012, S9: 002 |
[3] | Xie AN, Dong NG, Zhang KL, Xia JH, Xiao SL, Sun ZQ. Clinical experience in the use of marginal donor hearts. Chin Med J (Engl). 2011 Apr; 124(8):1185-8. |
[4] | Wang S, Li J, Xie A, et al. Dynamic changes in Th1, Th17, and FoxP3(+) T cells in patients with acute cellular rejection after cardiac transplantation. Clin Transplant, 2011, 25(3):177- 186 |
[5] | Ye P, Li J, Wang S, Xie A, et al. Eicosapentaenoic acid disrupts the balance between Tregs and IL-17+ T cells through PPARγ nuclear receptor activation and protects cardiac allografts. J Surg Res. 2012, 173(1):161-70 |
[6] | Xia Jiahong, Xie Aini, et al. The vascular endothelial growth factor expression and vascular regeneration in infarcted myocardium by skeletal muscle satellite cells. Chin Med J, 2006,119(2): 117-121 |
[7] | Wang S, Xu X, Xie A, et al. Anti-interleukin-12/23p40 antibody attenuates chronic rejection of cardiac allografts partly via inhibition δT cells. Clinical & Experimental Immunology, 2012, 169(3):320-329. |
[8] | Chen W, Xie A, Chan L. Mechanistic basis of immunotherapies for type 1 diabetes mellitus. Transl Res. 2013, 161(4):217-29 |
[9] | Schroder PM, Khattar M, Deng R, Xie A, Chen W, Stepkowski SM.Transient Combination Therapy Targeting the Immune Synapse Abrogates T Cell Responses and Prolongs Allograft Survival in Mice , PLoS One. 2013 Jul 24;8(7):e69397. |